SCHEMBL14348390

SCHEMBL14348390

Cc1ccc(-c2ccnc(Nc3ccccc3)n2)cc1C(=O)Nc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 5/20 0.64
▸ JAK3 P52333 1/20 0.64
▸ CAMK2D Q13557 2/20 0.58
▸ ABL1 P00519 7/20 0.56
▸ BCR P11274 6/20 0.56
▸ SRC P12931 2/20 0.56
▸ PRKCA P17252 5/20 0.56
▸ PDGFRB P09619 5/20 0.56
▸ PDGFRA P16234 5/20 0.56
▸ EGFR P00533 3/20 0.56
▸ PIK3CA P42336 1/20 0.55
▸ CAMKK2 Q96RR4 2/20 0.54
▸ CAMKK1 Q8N5S9 1/20 0.54
▸ PRKCD Q05655 2/20 0.53
▸ PRKD3 O94806 1/20 0.53
▸ PRKCG P05129 1/20 0.53
▸ PRKCB P05771 1/20 0.53
▸ PRKCH P24723 1/20 0.53
▸ PRKCI P41743 1/20 0.53
▸ PRKCE Q02156 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8349127 0.86 BTK (0.56) JAK2JAK3CAMK2DABL1BCR
SCHEMBL14348392 0.84 CAMKK2 (0.60) JAK2JAK3CAMK2DABL1BCR
SCHEMBL8349795 0.84 KDM4E (0.58) JAK2JAK3CAMK2DPIK3CACAMKK2
SCHEMBL8349440 0.82 BTK (0.54) JAK2JAK3ABL1BCRSRC
SCHEMBL14253908 0.81 ABL1 (0.59) JAK2JAK3CAMK2DABL1BCR
SCHEMBL14348389 0.81 SMG1 (0.56) JAK2JAK3CAMK2DABL1BCR
SCHEMBL4004743 0.81 CAMK2D (0.81) JAK2JAK3CAMK2DABL1BCR
SCHEMBL4383563 0.80 JAK2 (0.82) JAK2JAK3ABL1BCRSRC
SCHEMBL8351171 0.80 MAPK10 (0.58) JAK2PIK3CAMAPK8
SCHEMBL14253973 0.79 CAMK2D (0.67) JAK2JAK3CAMK2DABL1BCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312227-B2 Compositions useful as inhibitors of JAK and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-12-25 — — US disclosed
US-7312227-B2 Compositions useful as inhibitors of JAK and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-12-25 — — US disclosed
Send feedback